CCB Portal Please support MJHS Institute
Facebook Twitter YouTube LinkedIn

On-Demand Webinars:
Hospice 101: Levels of Care Across Settings

Note: Institutional group rates are available upon request

Select type to purchase:

Funding Disclosure: No commercial funding has been accepted for the activity.

Speaker
Speaker Name and Title:
Abby Nathanson, LCSW, ACS
Palliative Care Social Worker, NYU-Winthrop, Department of Palliative Medicine
Adjunct Faculty, New York University Silver School of Social Work

Purpose: The purpose of this webinar is to help social workers acquire the knowledge and skills to define different levels of care in palliative care and hospice and identify the role of the social worker. 

Objectives:

  1. Define levels of care in palliative care and hospice
  2. Identify trends in care at the end of life
  3. Recognize criteria for admission to hospice

Why Do I Need to Know This?
Palliative care and hospice are beneficial for patients and caregivers facing advanced and terminal illness, but they are poorly understood, and there are misperceptions which lead to late referral within a few days of death. Every team member has an important role to play. 

Target Audience:  Social workers and healthcare coaches

Criteria for Successful Completion:

  1. Attendance at entire session
  2. Submission of completed evaluation form
  3. Successful completion of a posttest (80% passing grade)

Continuing Education Credits: 1.0

Release Date: April 5, 2018

Expiration Date: January 31, 2019

Continuing Education Accreditation:

Social Workers: MJHS Institute for Innovation in Palliative Care SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0242.

 

Fees:
Individual:  $25 (includes CE certificate)

Disclosures
Abby Nathanson, LCSW, ACS, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with AstraZeneca Pharmaceuticals LP and Tabula Rasa for research support. 

No other Planning Committee Member has any disclosures.

Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhDc, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA